LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
6.48
+0.02 (0.31%)
At close: Dec 5, 2025, 4:00 PM EST
6.60
+0.12 (1.85%)
After-hours: Dec 5, 2025, 7:53 PM EST
LifeStance Health Group Market Cap
LifeStance Health Group has a market cap or net worth of $2.52 billion as of December 5, 2025. Its market cap has decreased by -9.01% in one year.
Market Cap
2.52B
Enterprise Value
2.79B
1-Year Change
-9.01%
Ranking
Category
Stock Price
$6.48
Market Cap Chart
Since the IPO on June 10, 2021, LifeStance Health Group's market cap has decreased from $6.73B to $2.52B, a decrease of -62.52%. That is a compound annual growth rate of -19.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.52B | -10.61% |
| Dec 31, 2024 | 2.82B | -4.87% |
| Dec 29, 2023 | 2.96B | 59.61% |
| Dec 30, 2022 | 1.86B | -47.85% |
| Dec 31, 2021 | 3.56B | -47.04% |
| Jun 10, 2021 | 6.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |